Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients

Neurogenetics

Volumn 13, Issue 2, 2012, Pages 181-187

  Schmied, Mascha C ^a   Zehetmayer, Sonja ^a   Reindl, Markus ^b   Ehling, Rainer ^b   Bajer Kornek, Barbara ^a   Leutmezer, Fritz ^a   Zebenholzer, Karin ^a   Hotzy, Christoph ^a   Lichtner, Peter ^c   Meitinger, Thomas ^c   Wichmann, H Erich ^c   Illig, Thomas ^c   Gieger, Christian ^c   Huber, Klaus ^d   Khalil, Michael ^e   Fuchs, Sigrid ^e   Schmidt, Helena ^e   Auff, Eduard ^a   Kristoferitsch, Wolfgang ^d   Fazekas, Franz ^e   Berger, Thomas ^b   Vass, Karl ^a   Zimprich, Alexander ^a   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d DANUBE HOSPITAL   (Austria)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Multiple sclerosis; Replication study; Risk genes

Indexed keywords

HLA DRB1 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; PROTEIN; UNCLASSIFIED DRUG; ZIC1 PROTEIN;

ADULT; ARTICLE; AUSTRIA; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC CORRELATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; REPLICATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; AGED; ALLELES; AUSTRIA; COHORT STUDIES; DNA; DNA REPLICATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX;

EID: 84862703405     PISSN: 13646745     EISSN: 13646753     Source Type: Journal    
DOI: 10.1007/s10048-012-0316-y     Document Type: Article

References (36)

1. Lyndsay JW (2005) Familiar recurrence rates and genetic models of multiple sclerosis. Am J Med Genet 135:53-58
2. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372 (9648):1502-1017
3. McElroy JP, Oksenberg JR (2008) Multiple sclerosis genetics. Curr Top Microbiol Immunol 318:45-72
4. The International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 357(9):851-862
5. International Multiple Sclerosis Genetics Consortium (IMSGC) (2008) Refining genetic associations in multiple sclerosis. Lancet Neurol 7(7):567-5699
6. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, Oturai A, Ryder LP, Saarele J, Harbbo HF, Celius EG, Salter H, Olsson T, Hillert J (2007) Variation in interleukin 7 receptor (IL7R) alpha gene influences risk of multiple sclerosis. Nat Genet 39(9):1108-1113
7. Weber F, Fontaine B, Cournu-Rebeix I, Kroner A, Knop M, Lutz S, Müller-Sarnowski F, Uhr M, Bettecken T, Kohli M et al (2008) IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes Immun 9 (3):259-263
8. Hoppenbrouwers IA, Aulchenko YS, Janssens AC, Ramagopalan SV, Broer L, Kayser M, Ebers GC, Oostra BA, van Duijn CM, Hintzen RQ (2009) Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis. J Hum Genet 54(11):676-680
9. Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, Chapman C, Bahlo M, Perera D, Johnson LJ, Tait BD, Varney MD, Speed TP, Taylor BV, Foote SJ, Butzkueven H, Kilpatrick TJ (2008) Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun 9 (7):624-630
10. Zoledziewska M, Costa G, Pitzalis M, Cocco E, Melis C, Moi ZP, Murru R, Longi R, Morelli et al (2009) Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia. Genes Immun 10 (1):15-17
11. Alcina A, Fernández O, Gonzalez JR, Catalá-Rabasa A, Fedetz M, Ndagire D, Lewa L, Guerrero M, Arnal C, Delgado C et al (2010) Tag-SNP analysis of the GFI1-EVI5-RPL5-FAM69 risk locus for multiple sclerosis. Eur J Hum Genet 18(7):827-831
12. Baranzini SE, Wong J, Gibson A, Galwey N, Naegelin BF, Radue EW, Linbdberg R, Uitdehaag B, Johnson M et al (2009) Genomewide association of susceptibility and clinical phenotype in multiple sclerosis. Human Mol Gen 18(4):767-777
13. Comabella M, Craig DW, Camiña-Tato M, Morcillo C, Lopez C, Navarro A, Rio J, BiomarkerMS Study Group, Montalban X, Martin R (2008) Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphisms. PLoS One 3(10):e3490
14. Alcina A, Fedetz M, Ndagire D, Fernández O, Leyva L, Guerrero M, Abad-Grau MM, Arnal C, Delgado C, Lucas M, Izquierdo G, Matesanz F (2009) IL2RA/CD25 gene polymorphisms: uneven association with multiple sclerosis (MS) and type 1 diabetes (T1D). PLoS One 4(1):e4137
15. Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C et al (2009) IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production. PloS Genet 5(1):e1000322
16. Aulchenko YS, Hoppenbrouwers IA, Ramagopalan SV, Broer L, Jafari N, Hillert J, Link J, Lundström W, Greiner E, Dessa Sadovnick A et al (2008) Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis. Nat Genet 40(12):1402-1403
17. Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C, Gustafsdottir SM, Sigurdsson S, Lundmark A, Tienari PJ et al (2008) Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Gent 45(6):362-369
18. Hoppenbrouwers IA, Aulchenko YS, Ebers GC, Ramagopalan SV, Oostra BA, van Duijn CM, Hintzen RQ (2008) EVI5 is a risk gene for multiple sclerosis. Genes Immun 9(4):334-337
19. International Multiple Sclerosis Genetics Consortium (IMSGC) (2009) The expanding genetic overlap between multiple sclerosis and type I diabetes. Genes Immun 10(1):11-14
20. Jensen CJ, Stankovich J, Van der Walt A, Bahlo M, Tylor BV, van der Mei I, Foote SJ, Sigurdsson S, Lundmark A, Tienari PJ et al (2010) Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patients. PLOS one 5(4):1-7
21. Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini E, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P et al (2009) Genotype-phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRO measures. Brain 132(1):250-259
22. Cournu-Rebeix I, Genin E, Leray E, Babron MC, Cohen J, Gout C, Alizadeh M, Perdry H, Semana G, Brassat D et al (2008) HLADRB1*15 allele influences the later course of relapsing remitting multiple sclerosis. Genes Immun 9(6):570-574
23. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, Mc Farland HF, Paty DW, Polman CH, Reingold SC et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121-127
24. Confavreux C, Vukusic S (2006) Natural history of multiple sclerosis: a unifying concept. Brain 129(3):606-661
25. Wichmann HE, Gieger C, Illig T, MONICA/KORA Study Group (2005) KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 (Suppl 1):S26-S30, Review
26. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9(7):811-818
27. Cavanillas ML, Fernández O, Comabella M, Alcina A, Fedetz M, Izquierdo G, Lucas M, Cenit MC, Arroyo R, Vandenbroeck K et al (2010) Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Genes Immun 12(2):110-115
28. Hishikawa D, Shindou H, Kobayashi S, Nakanishi H, Taguchi R, Shimizu T (2008) Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proc Natl Acad Sci U S A 105(8):2830-2835
29. Lin PI, Vance JM, Pericak-Vance MA, Martin ER (2007) No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80 (3):531-538
30. Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661-678
31. Weatherby SJ, Thomson W, Pepper L, Donn R, Worthington J, Mann CL, Davis MB, Fryer AA, Boggild MD, Young CA et al (2001) HLA-DRB1 and disease outcome in multiple sclerosis. J Neurol 248(4):304-310
32. Masterman T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J (2000) HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 48(2):211-219
33. Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, Roxburgh R, Coraddu F, Smith S, Compston DA (2002) HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 72(2):184-187
34. Smestad C, Brynedal B, Jonasdottir G, Lorentzen AR, Mastermann T, Akesson E, Spurkland A, Lie BA, Palmgren J et al (2007) The impact of HLA-A and DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients. Eur J Neurol 14(8):535-840
35. Brand OJ, Lowe CE, Heward JM, Franklyn JA, Cooper JD, Todd JA, Gough SC (2007) Association of the interleukin 2 receptor alpha (IL-2Ralpha)/CD25 gene region with Graves' disease using a multilocus test and tag SNPs. Clin Endocrinol 66(4):508-512
36. Skinningsrud B, Husebye ES, Pearce SH, McDonald DO, Brandal K, Wolff AB, Løvås K, Egeland T, Undlien DE (2008) Polymorphisms in CLEC16A and CIITA at 16p13 are associated with primary adrenal insufficiency. J Clin Endocrinol Metab 93(9):3310-3317